CSBR:NASDAQ
Champions Oncology Inc
4,68 USD
arrow_downward
−0,53%(−0,025) 1 D
16. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,68 USD
Høy
4,68 USD
Lav
4,68 USD
Markedsverdi
65,07 mill.
Snittvolum
8,15k
Volum
644,00
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,68 USD
Høy
4,68 USD
Lav
4,68 USD
Markedsverdi
65,07 mill.
Snittvolum
8,15k
Volum
644,00
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
Investing.com
·
for 16 minutter siden
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
for 1 time siden
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
for 41 minutter siden
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
for 1 time siden
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com